BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21630618)

  • 1. Persistent secondary hyperparathyroidism.
    Ağbaht K; Güllü S
    Acta Clin Belg; 2011; 66(2):149. PubMed ID: 21630618
    [No Abstract]   [Full Text] [Related]  

  • 2. COSMOS Project: Hemodialysis scenario in Europe.
    Cannata-Andía JB; Fernández Martín JL
    Nefrologia; 2016; 36(4):381-8. PubMed ID: 27117398
    [No Abstract]   [Full Text] [Related]  

  • 3. When, how, and why a bone biopsy should be performed in patients with chronic kidney disease.
    Torres PU; Bover J; Mazzaferro S; de Vernejoul MC; Cohen-Solal M
    Semin Nephrol; 2014 Nov; 34(6):612-25. PubMed ID: 25498380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Renal osteodystrophy. Physiopathological and clinical aspects].
    Farinelli A; Bedani PL; Gilli P
    Minerva Urol Nefrol; 1986; 38(4):417-24. PubMed ID: 3589887
    [No Abstract]   [Full Text] [Related]  

  • 5. Parathyroidectomy and renal insufficiency.
    Wilson RE
    Surg Annu; 1973; 5():121-43. PubMed ID: 4602212
    [No Abstract]   [Full Text] [Related]  

  • 6. Introduction: Mineral bone disorder is a key player in chronic kidney disease.
    Cozzolino M; Evenepoel P; Covic A
    Semin Nephrol; 2014 Nov; 34(6):577. PubMed ID: 25498376
    [No Abstract]   [Full Text] [Related]  

  • 7. Renal bone disease--an analysis of clinical, biochemical, radiological and histopathological findings.
    Rizvi SN; Gulati PD; Vaishnava H
    J Assoc Physicians India; 1974 Jul; 22(7):493-501. PubMed ID: 4436240
    [No Abstract]   [Full Text] [Related]  

  • 8. The uses and abuses of Vitamin D compounds in chronic kidney disease-mineral bone disease (CKD-MBD).
    Goldsmith DJ; Massy ZA; Brandenburg V
    Semin Nephrol; 2014 Nov; 34(6):660-8. PubMed ID: 25498384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leontiasis ossea in a patient with hyperparathyroidism secondary to chronic renal failure.
    Aggunlu L; Akpek S; Coskun B
    Pediatr Radiol; 2004 Aug; 34(8):630-2. PubMed ID: 15103427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prospective study of the effect of propanolol on Ca-P metabolism in chronic renal insufficiency].
    Pérez-García R; Jofre R; Vasconez F; Caballero A; Valderrábano F
    Rev Clin Esp; 1982 Feb; 164(3):159-52. PubMed ID: 7089332
    [No Abstract]   [Full Text] [Related]  

  • 11. [Renal osteodystrophy. II. Pathology and roentgen diagnosis].
    Raber-Durlacher JE; Schächter ME; Abraham-Inpijn L; Bras J; van Ooij CP; Wilmink JM
    Ned Tijdschr Geneeskd; 1983 Aug; 127(35):1578-84. PubMed ID: 6633697
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chronic arthralgia in a 46-year-old patient with renal failure].
    Schiller B; Hillebrand G; Bartl R; Linke RP
    Internist (Berl); 1992 Feb; 33(2):117-21. PubMed ID: 1568827
    [No Abstract]   [Full Text] [Related]  

  • 13. [Long-term treatment of secondary hyperparathyroidism in the chronic hemodialysis patient with 1,25-(OH)2D3].
    Giachino G; Giacchino F; Jeantet A; Del Piano A; Garetto A; Pellerey M; Piccoli G
    Minerva Med; 1985 Mar; 76(9-10):407-14. PubMed ID: 2984605
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chronic renal insufficiency and secondary hyperparathyroidism in rats. Biochemical and histological evaluation].
    Virgós MJ; Menéndez-Rodríguez P; Serrano M; González-Carcedo A; Braga S; Cannata JB
    Rev Esp Fisiol; 1993 Dec; 49(4):241-7. PubMed ID: 8209101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Renal osteodystrophy--more than a mere bone disease].
    Saha H
    Duodecim; 2001; 117(21):2181-7. PubMed ID: 12184205
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic kidney disease--mineral and bone disorder: a complex scenario.
    Mejía N; Roman-García P; Miar AB; Tavira B; Cannata-Andía JB
    Nefrologia; 2011; 31(5):514-9. PubMed ID: 21959717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological manifestations of abnormal parathyroid hormone metabolism in renal osteodystrophy.
    Teitelbaum SL
    Contrib Nephrol; 1988; 64():1-4. PubMed ID: 3180817
    [No Abstract]   [Full Text] [Related]  

  • 18. Mineral metabolism in chronic kidney disease.
    Kochanek M; Said A; Lerma EV
    Dis Mon; 2015 Oct; 61(10):425-33. PubMed ID: 26518114
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationship between aortic mineral elements and osteodystrophy in mice with chronic kidney disease.
    Matsumoto T; Fukushima S; Kanasaki T; Hagino S
    Biol Trace Elem Res; 2012 Dec; 150(1-3):278-84. PubMed ID: 22700181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D retains an important role in the pathogenesis and management of secondary hyperparathyroidism in chronic renal failure.
    Cozzolino M; Gallieni M; Brancaccio D; Arcidiacono T; Bianchi G; Vezzoli G
    J Nephrol; 2006; 19(5):566-77. PubMed ID: 17136683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.